3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
131
Liver Neoplasms
42
Carcinoma, Renal Cell
36
Leukemia, Myeloid, Acute
32
Neoplasm Metastasis
26
Breast Neoplasms
24
Carcinoma, Non-Small-Cell Lung
22
Kidney Neoplasms
16
Neoplasms
14
Prostatic Neoplasms
12
Pancreatic Neoplasms
12
Recurrence
11
Lung Neoplasms
11
Colorectal Neoplasms
10
Sarcoma
9
Melanoma
9
Brain Neoplasms
9
Myelodysplastic Syndromes
8
Glioblastoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Urinary Bladder Neoplasms
5
Thyroid Neoplasms
5
Rectal Neoplasms
5
Multiple Myeloma
5
Leukemia, Myelomonocytic, Chronic
5
Stomach Neoplasms
4
Ovarian Neoplasms
4
Liver Diseases
4
Gliosarcoma
4
Interventions
Etoposide
10
Cisplatin
9
Cyclophosphamide
7
etoposide phosphate
5
Paclitaxel
5
Ifosfamide
5
Granulocyte Colony-Stimulating Factor
5
Carboplatin
5
fludarabine
4
Sirolimus
4
Gemcitabine
4
pembrolizumab
3
fludarabine phosphate
3
Sunitinib
3
Mesna
3
Melphalan
3
Filgrastim
3
Drug Therapy
3
Brentuximab Vedotin
3
Bleomycin
3
Bevacizumab
3
Automobiles
3
tremelimumab
2
sodium thiosulfate
2
pegfilgrastim
2
lutetium Lu 177 dotatate
2
durvalumab
2
Vorinostat
2
Stem Cell Transplantation
2
Oxaliplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Germ Cell and Embryonal
×
Sorafenib
×
Clear all
NCT00772694
2008-10-24
GCT
Fondation Wygrajmy Zdrowie
Phase 2
Unknown
20 enrolled